Ophthalmic liposome capable of penetrating cornea and targeting retina, preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO LTD
- Publication Date
- 2021-07-27
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicine, and in particular relates to an ophthalmic liposome co-modified with a cell penetrating peptide CPP and hyaluronic acid HA capable of penetrating the cornea and targeting the retina, and a preparation method and application thereof. Background technique
[0002] The eye is an extremely complex and precise organ, anatomically divided into two parts: the anterior segment and the posterior segment. The anterior segment mainly includes the cornea, conjunctiva, aqueous humor, and lens, and the posterior segment mainly includes the vitreous, sclera, choroid, and retina. Intraocular neovascular diseases are mainly located in the posterior segment of the eye, such as retinopathy of prematurity (ROP), diabetic retinopathy (Diabetic retinopathy, DR) and age-related macular degeneration (Age-related macular degeneration, AMD), It is a serious blinding eye disease. Fundus neovascular diseases include chor...